HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Parul Agarwal Selected Research
Parul Agarwal Research Topics
Disease
11
Neoplasms (Cancer)
03/2024 - 01/2015
8
Epilepsy (Aura)
03/2024 - 01/2020
3
COVID-19
04/2024 - 08/2022
2
Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2024 - 01/2022
2
Seizures (Absence Seizure)
03/2024 - 01/2020
2
Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 01/2021
2
Microsatellite Instability
11/2023 - 01/2021
2
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2016
2
Sepsis (Septicemia)
01/2021 - 01/2021
1
Primitive Neuroectodermal Tumors (PNET)
04/2024
1
Pneumonia (Pneumonitis)
04/2024
1
Status Epilepticus (Complex Partial Status Epilepticus)
03/2024
1
Intracranial Hypertension
03/2024
1
Heart Failure
03/2024
1
Hypertension (High Blood Pressure)
03/2024
1
Hypotension (Low Blood Pressure)
03/2024
1
Respiratory Insufficiency (Respiratory Failure)
03/2024
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2024
1
Traumatic Brain Injuries (Traumatic Brain Injury)
07/2023
1
Glioma (Gliomas)
05/2023
1
Death (Near-Death Experience)
05/2023
1
Adenocarcinoma
11/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
11/2022
1
Lung Neoplasms (Lung Cancer)
01/2022
1
Disease Progression
01/2022
1
Hepatitis C
04/2021
1
Viremia
04/2021
1
Infections
04/2021
1
Brain Neoplasms (Brain Tumor)
01/2021
1
Dementia (Dementias)
01/2021
1
Ventricular Tachycardia
01/2019
1
Fibrosis (Cirrhosis)
01/2019
1
Myocarditis (Carditis)
01/2019
1
Chronic Disease (Chronic Diseases)
01/2016
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2016
Drug/Important Bio-Agent (IBA)
2
Capecitabine (Xeloda)
FDA Link
01/2024 - 11/2022
2
Biomarkers (Surrogate Marker)
IBA
11/2023 - 11/2022
1
trans-sodium crocetinate (crocetin)
IBA
04/2024
1
remdesivir
IBA
04/2024
1
Glucocorticoids
IBA
04/2024
1
Midazolam (Versed)
FDA Link
Generic
03/2024
1
Anesthetics (Anesthetic Agents)
IBA
03/2024
1
Ketamine
FDA Link
Generic
03/2024
1
Propofol (Diprivan)
FDA Link
Generic
03/2024
1
Proteins (Proteins, Gene)
FDA Link
11/2023
1
pembrolizumab
IBA
11/2023
1
Cisplatin (Platino)
FDA Link
Generic
11/2022
1
130-nm albumin-bound paclitaxel
IBA
11/2022
1
Gemcitabine
FDA Link
11/2022
1
Irinotecan (Camptosar)
FDA Link
Generic
11/2022
1
Cell-Free Nucleic Acids
IBA
11/2022
1
Vaccines
IBA
08/2022
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2022
1
Capsules (Microcapsules)
IBA
01/2022
1
Radioisotopes (Radionuclides)
IBA
01/2022
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
04/2021
1
CTLA-4 Antigen
IBA
01/2021
1
4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)
IBA
01/2021
1
Calcibiotic Root Canal Sealer
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
12/2019
1
Infliximab (Remicade)
FDA Link
01/2019
1
insulin receptor-related receptor (IRR)
IBA
01/2016
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
01/2016
1
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
01/2016
Therapy/Procedure
6
Therapeutics
11/2023 - 01/2015
4
Drug Therapy (Chemotherapy)
01/2024 - 01/2022
4
Length of Stay
01/2021 - 01/2020
3
Liver Transplantation
01/2022 - 01/2019
2
Mechanical Ventilators (Ventilator)
04/2024 - 10/2023
2
Immunotherapy
11/2023 - 01/2021
2
Radiotherapy
01/2022 - 01/2018
2
Patient Readmission
01/2021 - 01/2021
1
Ambulatory Care (Outpatient Care)
03/2024
1
Contraindications
03/2024
1
Critical Care (Surgical Intensive Care)
03/2024
1
Polypharmacy
07/2023
1
Palliative Care (Palliative Therapy)
05/2023
1
Operative Surgical Procedures
01/2021
1
Vagus Nerve Stimulation
01/2020
1
Deep Brain Stimulation
01/2020
1
Patient Discharge
01/2020
1
Neoadjuvant Therapy
01/2018
1
Mastectomy (Mammectomy)
01/2018
1
Radiofrequency Ablation
05/2016